| pubmed-article:17582802 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17582802 | lifeskim:mentions | umls-concept:C1140680 | lld:lifeskim |
| pubmed-article:17582802 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:17582802 | lifeskim:mentions | umls-concept:C0166417 | lld:lifeskim |
| pubmed-article:17582802 | lifeskim:mentions | umls-concept:C1257954 | lld:lifeskim |
| pubmed-article:17582802 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:17582802 | lifeskim:mentions | umls-concept:C0018270 | lld:lifeskim |
| pubmed-article:17582802 | lifeskim:mentions | umls-concept:C0083381 | lld:lifeskim |
| pubmed-article:17582802 | lifeskim:mentions | umls-concept:C0023688 | lld:lifeskim |
| pubmed-article:17582802 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:17582802 | lifeskim:mentions | umls-concept:C0055721 | lld:lifeskim |
| pubmed-article:17582802 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:17582802 | pubmed:dateCreated | 2007-8-8 | lld:pubmed |
| pubmed-article:17582802 | pubmed:abstractText | It was recently reported that high expression of peroxisome proliferator-activated receptor gamma (PPARgamma) and low expression of cyclooxygenase-2 (COX-2) might be involved in the inhibition of ovarian tumor progression and confirmed that PPARgamma activation could suppress COX-2 expression via the nuclear factor-kappaB pathway in ovarian cancer cells. | lld:pubmed |
| pubmed-article:17582802 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17582802 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17582802 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:17582802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17582802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17582802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17582802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17582802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17582802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17582802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17582802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17582802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17582802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17582802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17582802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17582802 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17582802 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:17582802 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:17582802 | pubmed:author | pubmed-author:BurtF BFB | lld:pubmed |
| pubmed-article:17582802 | pubmed:author | pubmed-author:MizunumaHidek... | lld:pubmed |
| pubmed-article:17582802 | pubmed:author | pubmed-author:YokoyamaYoshi... | lld:pubmed |
| pubmed-article:17582802 | pubmed:author | pubmed-author:FutagamiMasay... | lld:pubmed |
| pubmed-article:17582802 | pubmed:author | pubmed-author:ShigetoTatsuh... | lld:pubmed |
| pubmed-article:17582802 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17582802 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:17582802 | pubmed:volume | 110 | lld:pubmed |
| pubmed-article:17582802 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17582802 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17582802 | pubmed:pagination | 791-800 | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:meshHeading | pubmed-meshheading:17582802... | lld:pubmed |
| pubmed-article:17582802 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17582802 | pubmed:articleTitle | Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers. | lld:pubmed |
| pubmed-article:17582802 | pubmed:affiliation | Department of Obstetrics and Gynecology, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan. | lld:pubmed |
| pubmed-article:17582802 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17582802 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17582802 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17582802 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17582802 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17582802 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17582802 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17582802 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17582802 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17582802 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17582802 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17582802 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17582802 | lld:pubmed |
